BACKGROUND: Few studies have systematically investigated the association between PARKIN genotype and psychiatric co-morbidities of Parkison's disease (PD). PARKIN-associated PD is characterized by severe nigral dopaminergic neuronal loss, a finding that may have implications for behaviors rooted in dopaminergic circuits such as obsessive-compulsive symptoms (OCS). METHODS: The Schedule of Compulsions and Obsessions Patient Inventory (SCOPI) was administered to 104 patients with early-onset PD and 257 asymptomatic first-degree relatives. Carriers of one and two PARKIN mutations were compared with noncarriers. RESULTS: Among patients, carriers scored lower than noncarriers in adjusted models (one-mutation: 13.9 point difference, P = 0.03; two-mutation: 24.1, P = 0.001), where lower scores indicate less OCS. Among asymptomatic relatives, a trend toward the opposite was seen: mutation carriers scored higher than noncarriers (one mutation, P = 0.05; two mutations, P = 0.13). CONCLUSIONS: First, a significant association was found between PARKIN mutation status and obsessive-compulsive symptom level in both PD and asymptomatic patients, suggesting that OCS might represent an early non-motor dopamine-dependent feature. Second, irrespective of disease status, heterozygotes were significantly different from noncarriers, suggesting that PARKIN heterozygosity may contribute to phenotype.
BACKGROUND: Few studies have systematically investigated the association between PARKIN genotype and psychiatric co-morbidities of Parkison's disease (PD). PARKIN-associated PD is characterized by severe nigral dopaminergic neuronal loss, a finding that may have implications for behaviors rooted in dopaminergic circuits such as obsessive-compulsive symptoms (OCS). METHODS: The Schedule of Compulsions and ObsessionsPatient Inventory (SCOPI) was administered to 104 patients with early-onset PD and 257 asymptomatic first-degree relatives. Carriers of one and two PARKIN mutations were compared with noncarriers. RESULTS: Among patients, carriers scored lower than noncarriers in adjusted models (one-mutation: 13.9 point difference, P = 0.03; two-mutation: 24.1, P = 0.001), where lower scores indicate less OCS. Among asymptomatic relatives, a trend toward the opposite was seen: mutation carriers scored higher than noncarriers (one mutation, P = 0.05; two mutations, P = 0.13). CONCLUSIONS: First, a significant association was found between PARKIN mutation status and obsessive-compulsive symptom level in both PD and asymptomatic patients, suggesting that OCS might represent an early non-motor dopamine-dependent feature. Second, irrespective of disease status, heterozygotes were significantly different from noncarriers, suggesting that PARKIN heterozygosity may contribute to phenotype.
Authors: R Hilker; C Klein; M Ghaemi; B Kis; T Strotmann; L J Ozelius; O Lenz; P Vieregge; K Herholz; W D Heiss; P P Pramstaller Journal: Ann Neurol Date: 2001-03 Impact factor: 10.422
Authors: C Buhmann; F Binkofski; C Klein; C Büchel; T van Eimeren; C Erdmann; K Hedrich; M Kasten; J Hagenah; G Deuschl; P P Pramstaller; H R Siebner Journal: Brain Date: 2005-06-09 Impact factor: 13.501
Authors: Rüdiger Hilker; Christine Klein; Katja Hedrich; Laurie J Ozelius; Peter Vieregge; Karl Herholz; Peter P Pramstaller; Wolf Dieter Heiss Journal: Neurosci Lett Date: 2002-04-19 Impact factor: 3.046
Authors: Martine Visser; Albert F G Leentjens; Johan Marinus; Anne M Stiggelbout; Jacobus J van Hilten Journal: Mov Disord Date: 2006-05 Impact factor: 10.338
Authors: Lorraine N Clark; Shehla Afridi; Eric Karlins; Yuanjia Wang; Helen Mejia-Santana; Juliette Harris; Elan D Louis; Lucien J Cote; Howard Andrews; Stanley Fahn; Cheryl Waters; Blair Ford; Steven Frucht; Ruth Ottman; Karen Marder Journal: Arch Neurol Date: 2006-04
Authors: Ebba Lohmann; Magali Periquet; Vincenzo Bonifati; Nick W Wood; Giuseppe De Michele; Anne-Marie Bonnet; Valérie Fraix; Emmanuel Broussolle; Martin W I M Horstink; Marie Vidailhet; Patrice Verpillat; Thomas Gasser; David Nicholl; Hélio Teive; Salmo Raskin; Olivier Rascol; Alain Destée; Merle Ruberg; Francesca Gasparini; Giuseppe Meco; Yves Agid; Alexandra Durr; Alexis Brice Journal: Ann Neurol Date: 2003-08 Impact factor: 10.422
Authors: Naheed L Khan; Elizabeth Graham; Peter Critchley; Anette E Schrag; Nicholas W Wood; Andrew J Lees; Kailash P Bhatia; Niall Quinn Journal: Brain Date: 2003-06 Impact factor: 13.501
Authors: Francesca Morgante; Alfonso Fasano; Monia Ginevrino; Simona Petrucci; Lucia Ricciardi; Francesco Bove; Chiara Criscuolo; Marcello Moccia; Anna De Rosa; Chiara Sorbera; Anna Rita Bentivoglio; Paolo Barone; Giuseppe De Michele; Maria Teresa Pellecchia; Enza Maria Valente Journal: Neurology Date: 2016-09-02 Impact factor: 9.910